Trump Admin Meets With Pro-Life Groups to Review Experiments on Aborted Babies’ Remains

Trump administration health officials are meeting with national pro-life leaders in hopes of resolving concerns over the pro-life administration’s continued funding of medical research using tissue obtained from aborted babies.

In August, a notice from the U.S. Food and Drug Administration (FDA) surfaced detailing a contract to the fetal tissue procurement firm Advanced Bioscience Resources, Inc. (ABR) to acquire “Tissue for Humanized Mice.” The tissue was meant to give mice a “humanized” immune system for the purpose of drug testing.

Forty-eight pro-life leaders representing LifeSiteNews, the Center for Medical Progress, Susan B. Anthony List, Priests for Life, Operation Rescue, and other groups sent a letter to Health and Human Services (HHS) Secretary Alex Azar on September 11 demanding the contract’s cancellation. Eighty-five U.S. House members sent a letter to FDA commissioner Scott Gottlieb, as well.

The administration terminated the contract in September and promised to review all remaining research involving fetal tissue, but concerns remained over nearly $100 million in tax dollars that continued to pay for other research using tissue and organs from aborted babies.

Last week, the administration began to arrange meetings to discuss cancelling the remaining projects, Politico reported Tuesday. Both sides of the issue will be represented, with scientists who use fetal tissue invited to defend their work and pro-life groups such as Susan B. Anthony List invited to critique it. (Read more from “Trump Admin Meets With Pro-Life Groups to Review Experiments on Aborted Babies’ Remains” HERE)

Follow Joe Miller on Twitter HERE and Facebook HERE.